EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
CHEBI:CHEBI_50914
Definition
An inhibitor of phosphatidylinositol 3-kinase, EC 2.7.1.137, a family of related enzymes capable of phosphorylating the 3 position hydroxy group of the inositol ring of a phosphatidylinositol.
Alternative Names
- 1-phosphatidylinositol 3-kinase inhibitor
- 1-phosphatidylinositol 3-kinase inhibitors
- ATP:1-phosphatidyl-1D-myo-inositol 3-phosphotransferase inhibitor
- ATP:1-phosphatidyl-1D-myo-inositol 3-phosphotransferase inhibitors
- EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitors
- EC 2.7.1.137 inhibitor
- EC 2.7.1.137 inhibitors
- phosphatidylinositol 3-kinase (EC 2.7.1.137) inhibitor
- phosphatidylinositol 3-kinase (EC 2.7.1.137) inhibitors
- phosphatidylinositol 3-kinase inhibitor
- phosphatidylinositol 3-kinase inhibitors
- phosphatidylinositol-3-OH kinase inhibitor
- phosphatidylinositol-3-OH kinase inhibitors
- phosphoinositide 3-kinase inhibitor
- phosphoinositide 3-kinase inhibitors
- PI-3 kinase inhibitor
- PI-3 kinase inhibitors
- PI(3)K inhibitor
- PI(3)K inhibitors
- PI3-kinase inhibitor
- PI3-kinase inhibitors
- PI3K inhibitor
- PI3K inhibitors
- PtdIns-3-kinase inhibitor
- PtdIns-3-kinase inhibitors
- type I phosphatidylinositol kinase inhibitor
- type I phosphatidylinositol kinase inhibitors
- type III phosphoinositide 3-kinase inhibitor
- type III phosphoinositide 3-kinase inhibitors
- Vps34p inhibitor
- Vps34p inhibitors
Treatment Applications
Drug Classification
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:50914
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#id
- CHEBI:50914
- core#notation
- CHEBI:50914
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_104049
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_173077
- owl#someValuesFrom
- t303671
- owl#annotatedSource
- t238709